Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Study Type: Interventional"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Rheumatoid+Arthritis%22&type=Subject&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22
/vufind/Search/Results?lookfor=%22Rheumatoid+Arthritis%22&type=Subject&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22
Search /vufind/Search2/Results?lookfor=%22Rheumatoid+Arthritis%22&type=Subject&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22
PubPharm (8.651)
1
A Phase 3b/4 Study in Rheumatoid Arthritis : A Randomized, Active Controlled, Parallel Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis. - RA-BRIDGE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-a) Inhibitor Therapy - Clinical Rheumatoid Arthritis Development for Olokizumab (CREDO) 3
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A Phase 3 Study in Moderate to Severe Rheumatoid Arthritis. : A Randomized, Double-Blind, Placebo- and Active Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy. - RA-BEAM
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Efficacy and safety of GSK3196165 versus placebo and sarilumab in participants with moderately to severely active rheumatoid arthritis who have an inadequate response to biological DMARDs and/or Janus Kinase inhibitors. : A 24-week, phase 3, multicentre, randomised, double-blind, efficacy and safety study, comparing GSK3196165 with placebo and with sarilumab, in combination with conventional synthetic DMARDs, in participants with moderately to severely active rheumatoid arthritis who have an inadequate response to biological DMARDs and/or Janus Kinase inhibitors. - contRAst-3
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-a) Inhibitor Therapy : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-a) Inhibitor Therapy - Clinical Rheumatoid Arthritis Development for Olokizumab (CREDO) 3
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Study to Compare Upadacitinib (ABT-494) to Placebo in Subjects with Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who have an Inadequate Response or Intolerance to Biologic DMARDs (SELECT-BEYOND) : A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Filgotinib Alone or in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have Not Yet Started Methotrexate Treatment : A Randomized, Double-blind, Placebo-and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Are Naïve to MTX Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A study comparing the use of etanercept and methotrexate, used either alone or in combination, for maintaining remission in rheumatoid arthritis. : A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Phase 3b/4 Study in Rheumatoid Arthritis : A Randomized, Active Controlled, Parallel Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis. - RA-BRIDGE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Multicenter, Randomized, Parallel-Group, Active-Controlled Double-Blind Study Conducted Under In-House Blinding Conditions to Determine the Incidence of Gastroduodenal Ulcers in Patients With Osteoarthritis or Rheumatoid Arthritis After 12 Weeks of Treatment With L-001069957 21 mg Plus Low-Dose Aspirin, L- 01069957 42 mg Plus Low-Dose Aspirin, Celecoxib 400 mg Plus Low-Dose Aspirin, or Low-Dose Aspirin Alone - 12-Week NO-Rofecoxib Plus Aspirin Endoscopy Study : A Multicenter, Randomized, Parallel-Group, Active-Controlled Double-Blind Study Conducted Under In-House Blinding Conditions to Determine the Incidence of Gastroduodenal Ulcers in Patients With Osteoarthritis or Rheumatoid Arthritis After 12 Weeks of Treatment With L-001069957 21 mg Plus Low-Dose Aspirin, L- 01069957 42 mg Plus Low-Dose Aspirin, Celecoxib 400 mg Plus Low-Dose Aspirin, or Low-Dose Aspirin Alone - 12-Week NO-Rofecoxib Plus Aspirin Endoscopy Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[866]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Study Type: Interventional
Medienart
8.651
Aufsätze
8.651
E-Artikel
8.651
E-Ressourcen
Zeitschriftentitel
7.360
WHO International Clinical Trials Registry Plat...
1.291
ClinicalTrials.gov
Thema
8.651
610
Study Type: Interventional
4.885
Recruitment Status: Not yet recruiting
1.766
Recruitment Status: Completed
1.702
Phase: Phase 3
1.307
Medical Condition: Rheumatoid Arthritis
1.234
Arthritis
1.170
Phase: Phase 2
1.163
Arthritis, Rheumatoid
674
Phase: Phase 4
664
Recruitment Status: Recruiting
500
Recruitment Status: Authorised-recruitment may ...
364
Medical Condition: Rheumatoid arthritis
352
Phase: Phase 1
270
Recruitment Status: Complete: follow-up complete
202
Medical Condition: rheumatoid arthritis
154
Medical Condition: Rheumatoid Arthritis MedDRA ...
143
Recruitment Status: Terminated
136
Medical Condition: Rheumatoid arthritis MedDRA ...
133
Phase: Phase 2/Phase 3
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.386
2020-
5.195
2010-2019
70
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8.367
Englisch
196
Unbestimmt
52
Spanisch
10
Niederländisch
8
Französisch
4
Italienisch
2
Dänisch
2
Finnisch
2
Galizisch
2
Deutsch
2
Irisch
2
Sanskrit
2
Schwedisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...